Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2123 (LINC02123)

Target
LINC02123
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other (non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2123 (LINC02123) is a human gene that produces a long intergenic non-coding RNA transcript. As part of the lincRNA class, it is distinguished from other lncRNAs by being transcribed from intergenic regions and not overlapping with protein-coding genes. LINC02123 and related lincRNAs play regulatory roles in gene expression, chromatin architecture, and RNA stability, often with considerable tissue specificity. Recent research highlights LINC02123 as a promising biomarker for lung cancer diagnosis, offering utility in non-invasive diagnostic models, including potential blood-based detection methods. It has been identified as a differentially expressed lncRNA in lung cancer datasets, with its downregulation potentially distinguishing tumor from normal samples. Its mechanisms are largely epigenetic or transcriptional, with no current evidence of peptide-coding potential or direct druggability. The clinical use of LINC02123 is primarily as a diagnostic biomarker rather than a therapeutic target.

Other names
LINC02123
02

Biological functions

Transcription regulationEpigenetic regulationChromatin remodelingRNA stabilizationFine-tuning expression of neighboring genes
03

Disease associations

Cancer (specifically lung cancer biomarker)Other (potential relevance in other cancers, but primarily investigated in lung cancer)
04

Biomarkers

Lung cancer detection (proposed blood/tissue biomarker for distinguishing cancer from normal tissue)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2123 (LINC02123).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2123 (LINC02123).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call